We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · March 08, 2021

A PD‑L1/PD‑1/CD8 Axis–Based Classifer to Predict Cancer Survival of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy

Cancer Immunology, Immunotherapy: CII

 

Additional Info

Cancer Immunology, Immunotherapy: CII
Development and Validation of a PD‑L1/PD‑1/CD8 Axis‑Based Classifer to Predict Cancer Survival of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
Cancer Immunol. Immunother. 2021 Feb 19;[EPub Ahead of Print], J Chen, W Zhong, M Yang, et al

Further Reading